ConductScience.org, home

Paper23909475

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.

Hüffmeier U and 4 others. Br J Dermatol, 2014. Cited by 85 papers, by iCite.

Cite this record

ConductScience Library. Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations. Papers, record 23909475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23909475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.
PubMed
Journal
Br J Dermatol
PubMed
Year
2014
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
2.92
iCite
Revised in PubMed
2014-01-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hüffmeier UU
2Wätzold MM
3Mohr JJ
4Schön MPM P
5Mössner RR

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dermatologic AgentsMajor topic
Interleukin 1 Receptor Antagonist ProteinMajor topic
InterleukinsMajor topic
MutationMajor topic
PsoriasisMajor topic
Female
Humans
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in24641215Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?https://conductscience.org/library/papers/24641215

Source PubMed

Download CSV of comments and corrections

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
39027700Biologics as a novel treatment option for palmoplantar pustulosis: a comprehensive review.Postepy Dermatol Alergol2024https://conductscience.org/library/papers/39027700PubMed
38448036Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26.J Exp Med2024https://conductscience.org/library/papers/38448036PubMed
38114719Spesolimab for the Treatment of Generalized Pustular Psoriasis.Drugs2024https://conductscience.org/library/papers/38114719PubMed
38103162Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications.Clin Rev Allergy Immunol2023https://conductscience.org/library/papers/38103162PubMed
37958609Treatment Strategies in Neutrophilic Dermatoses: A Comprehensive Review.Int J Mol Sci2023https://conductscience.org/library/papers/37958609PubMed
37631866Pustular Eruption following COVID-19 Vaccination: A Narrative Case-Based Review.Vaccines (Basel)2023https://conductscience.org/library/papers/37631866PubMed
37372477Genetics of Generalized Pustular Psoriasis: Current Understanding and Implications for Future Therapeutics.Genes (Basel)2023https://conductscience.org/library/papers/37372477PubMed
36779688Pathophysiology of generalized pustular psoriasis.Exp Dermatol2023https://conductscience.org/library/papers/36779688PubMed
36704338Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations.Front Genet2022https://conductscience.org/library/papers/36704338PubMed
35997892The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases.Adv Ther2022https://conductscience.org/library/papers/35997892PubMed
35704168Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments.Am J Clin Dermatol2022https://conductscience.org/library/papers/35704168PubMed
35061230Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.Am J Clin Dermatol2022https://conductscience.org/library/papers/35061230PubMed
34944562Pustular Psoriasis: From Pathophysiology to Treatment.Biomedicines2021https://conductscience.org/library/papers/34944562PubMed
34626330Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.Dermatol Ther (Heidelb)2021https://conductscience.org/library/papers/34626330PubMed
34445754Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity.Int J Mol Sci2021https://conductscience.org/library/papers/34445754PubMed
34411292Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).Br J Dermatol2021https://conductscience.org/library/papers/34411292PubMed
33955502An update on genetic basis of generalized pustular psoriasis (Review).Int J Mol Med2021https://conductscience.org/library/papers/33955502PubMed
33796114IL-1 Family Antagonists in Mouse and Human Skin Inflammation.Front Immunol2021https://conductscience.org/library/papers/33796114PubMed
32814870"Autoinflammatory psoriasis"-genetics and biology of pustular psoriasis.Cell Mol Immunol2021https://conductscience.org/library/papers/32814870PubMed
32253451[Autoinflammatory skin diseases : Diagnosis and therapy].Hautarzt2020https://conductscience.org/library/papers/32253451PubMed

See all 44 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL36RN26525PubTator's text mininghttps://conductscience.org/library/genes/26525

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23909475

GET https://conductscience.org/api/papers/v1/23909475/cited_by?page=2